Picture this. You are a Vestact client and you wake up on a Saturday morning, make yourself a coffee and check your emails. Your weekly mini-statement pops up and you scroll through it briefly. Looking good, nice to see Stryker above $260 a share again. You delete the email and go for a run.
Meanwhile over in Kalamazoo, Michigan, Stryker has just received FDA clearance for the first-ever balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears. This balloon is biodegradable and is slowly absorbed by the body when it is not needed.
That is the beauty of owning shares. You have the best people working for you while you sleep. It's a line item on your statement once a week, but these companies are doing incredible things in the real world.
If you are interested, you can read more about this medical breakthrough here.
http://www.vestact.com/images/balloon_jul_21.png